Form 4: Astera Labs CEO Executes Pre-Planned Stock Sales Totaling Over 18,000 Shares

Astera Labs, Inc. CEO Jitendra Mohan sold 18,264 shares of common stock across two days in July 2025, pursuant to a pre-arranged Rule 10b5-1 trading plan.

Summary

• Jitendra Mohan, Chief Executive Officer and Director of Astera Labs, Inc. (ALAB), reported the sale of 18,264 shares of the company's common stock.
• The sales occurred on two separate dates: 6,982 shares were sold on July 9, 2025, and 11,282 shares were sold on July 10, 2025.
• The shares sold on July 9, 2025, had a weighted average price of $100.0092, with individual transactions ranging from $100.0000 to $100.0800.
• The shares sold on July 10, 2025, had a weighted average price of $102.4607, with individual transactions ranging from $102.0400 to $103.0350 for 10,909 shares, and $103.1350 for 373 shares.
• These transactions were executed automatically under a Rule 10b5-1 trading plan adopted by Mr. Mohan on December 2, 2024.
• Following these sales, Mr. Mohan's beneficial ownership, including direct holdings and indirect holdings through various trusts, totals 9,699,154 shares of Astera Labs common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While insider selling can be perceived negatively, the fact that it was executed under a pre-arranged Rule 10b5-1 plan mitigates concerns about opportunistic selling. The sales also occurred at favorable price points for the seller.

Positives

• The stock sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating they were scheduled in advance and not a reaction to recent non-public information.
• The sales occurred at relatively high price points, with weighted average prices of $100.0092 and $102.4607, reflecting a strong valuation for Astera Labs' stock at the time of the transactions.

Negatives

• The transactions represent a reduction in the direct and indirect beneficial ownership of Astera Labs common stock by a key executive, which can sometimes be perceived negatively by investors.

Risks

• No specific risks are detailed in this Form 4 filing beyond the general market perception associated with insider stock sales, even when pre-planned.

Future Outlook

This Form 4 filing does not provide any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• Jitendra Mohan disclaims beneficial ownership of the securities held indirectly through various trusts, except to the extent of his pecuniary interest therein, stating that the filing is not an admission of beneficial ownership for Section 16 or any other purpose.

Industry Context

This filing is specific to an insider transaction at Astera Labs, Inc. and does not provide information directly related to broader industry trends or competitive dynamics.

Comparison to Industry Standards

• Insider stock sales executed under a Rule 10b5-1 trading plan are a common practice among executives in publicly traded companies across various industries, including the semiconductor and data infrastructure sectors where Astera Labs operates.
• The use of a 10b5-1 plan aligns with best practices for corporate insiders to sell shares in a pre-scheduled manner, mitigating concerns about trading on material non-public information.

Related Party Transactions

• The transactions involve the sale of shares by the Chief Executive Officer and Director, Jitendra Mohan, who is a related party to Astera Labs, Inc.
• Shares were sold from accounts held indirectly through various estate planning trusts (Living Trust, Trust, 2021 Trust 1, 2021 Trust 2, 2022 Trust 1, 2022 Trust 2), which are considered related parties.

Stakeholder Impact

• Shareholders may observe a reduction in the CEO's beneficial ownership, though the pre-planned nature of the sales (Rule 10b5-1) typically lessens any negative interpretation.
• The transactions do not directly impact employees, customers, suppliers, or creditors, as they relate solely to the personal stock holdings of an executive.

Next Steps

• The Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price within the reported ranges upon request to the Issuer, any security holder, or the SEC staff.

Key Dates

Keywords

Astera Labs, ALAB, Jitendra Mohan, Insider Trading, Form 4, Stock Sale, CEO, 10b5-1 Plan, Beneficial Ownership